mobocertinib
Takeda Pharms USA
To treat locally advanced or metastatic non-small cell lung cancer with epidermal growth factor receptor exon 20 insertion mutations
The fda-analyst skill answers natural-language questions about this approval by fetching the relevant FDA review PDFs at query time.
git clone https://github.com/cbetz/trove
cp -r trove/skills/fda-analyst ~/.claude/skills/
Example prompts for Exkivity: